Gene transfer to long-term repopulating hematopoietic stem cells (HSCs) using integrating viral vectors is an important goal in gene therapy. The SLAM (signaling lymphocyte activation molecule)-family receptors have recently been used for the isolation of highly enriched murine HSCs. This HSC enrichment protocol is relatively simple, and results in an HSC population with comparable repopulating capacity to c-kit + lin À Sca-1 + (KSL) HSCs. The capacity to withstand genetic manipulation and, most importantly, to maintain long-term repopulating capacity of SLAM-enriched HSC populations has not been reported. In this study, SLAMenriched HSCs were assessed for transduction efficiency and in vivo long-term repopulating capacity after lentiviral transduction using an abbreviated transduction protocol and KSL-enriched HSCs as a reference population. SLAM-and KSL-enriched HSCs were efficiently transduced by lentiviral vector using a simple protocol that involves minimal in vitro manipulation and no pre-stimulation. SLAM-HSCs are at least equal to KSL-HSCs with respect to efficiency of transduction and maintenance of long-term repopulating capacity. Although there was a reduction in repopulating capacity related to enrichment and culture manipulations relative to freshly isolated bone marrow (BM) cells, no detrimental effects were identified on long-term competitive capacity related to transduction, as transduced cells maintained stable levels of chimerism in competition with nontransduced cells and freshly isolated BM cells. These results support the SLAM-HSC enrichment protocol as a simple and efficient method for HSC enrichment for gene transfer studies.
Introduction
Hematopoietic stem cells (HSCs) represent a self-renewing population of cells capable of giving rise to all of the cellular components of blood. In that context, HSCs have enormous potential for therapeutic application in transplantation and regenerative medicine. HSCs have been prospectively isolated by a variety of enrichment protocols. The ability to enrich HSCs in combination with the success of HSC transplantation offers the opportunity for genetic manipulation of the hematopoietic compartment as a therapeutic strategy for treatment of multiple genetic disorders. To achieve this goal, efficient transduction of enriched HSCs must be accomplished with preservation of their long-term repopulating capacity after transplantation.
Hematopoietic stem cell enrichment strategies have most commonly used lineage depletion with positive selection for specific cell surface markers 1 or dye efflux properties that are specific to HSCs, 2, 3 or a combination of both. A commonly used strategy for cell surface marker selection has been the c-Kit + , Sca-1 + , lineage marker negative (lin À/lo ) cell surface scheme for isolation of so called 'KSL (c-kit + lin À Sca-1 + )' cells. 4 Although this scheme allows isolation of an enriched population of HSCs, it requires a large number of antibodies and extensive manipulation of cells. More recently, the SLAM (signaling lymphocyte activation molecule) family of cell surface markers have been identified as useful markers for the isolation of highly enriched murine HSCs. 5, 6 This HSC enrichment protocol is relatively simple, and results in an enriched HSC product that has been shown to have comparable repopulating capacity to KSL-enriched HSC.
Vector-based gene transfer to enriched HSCs requires the additional process of culture transduction before transplantation. Lentiviral vectors have proven to be promising for therapeutic applications because of their ability to transduce non-dividing cells with integration of the encoded transgene into the host genome, and the decreased risk of insertional mutagenesis relative to the retroviral vectors. 7, 8 Protocols for lentiviral transduction of HSCs have evolved over the years with a recent trend toward abbreviated culture times and minimal cytokine exposure, to avoid differentiation, and loss of long-term repopulating capacity after transplantation. [9] [10] [11] [12] In addition to loss of repopulating capacity, transduction of HSCs has been shown to result in loss of homing capacity 13 and may have other detrimental effects. Thus, the process of HSC enrichment and subsequent gene transfer may result in significant reduction of HSC repopulating capacity by a variety of mechanisms.
The purpose of this study was to assess the practical utility of a simple SLAM enrichment protocol and abbreviated transduction protocol for hematopoietic gene transfer studies. Specifically, a SLAM-enriched HSC population was assessed for (1) transduction efficiency and (2) in vivo long-term repopulating capacity after lentiviral transduction, with KSL-enriched cells as a reference for comparison.
The SLAM family is a large group of cell surface glycoproteins in the immunoglobulin superfamily 14 of which two (CD150 and CD48) have been identified as useful in the purification of HSCs. 5, 6, 15 The initial study by Kiel et 4 Although highly enriched for HSCs, this population is heterogeneous, and depending on the mouse strain used contains around 10% HSCs. We chose to use this population as a reference population in this study because it is commonly used and was the standard in our laboratory before introduction of SLAM enrichment. For SLAM enrichment, we wanted to assess an enrichment protocol that did not require flow cytometric sorting, a time consuming and expensive process that is fairly stressful to cells. Therefore, we used a SLAM-based enrichment that consists of a simple, two-step magnetic bead selection protocol. This resulted in the rapid selection of a population that consisted of 490% CD150 + CD48 À cells. To assess transduction efficiency of our lentiviral vector (Figure 1 ), we analyzed aliquots of cells taken from each transduced population after 72 h in liquid culture for green fluorescent protein (GFP) expression. The transduction efficiency of both populations ranged between 60 and 70%, with no significant difference between the SLAM-and the KSL-isolated cells. As expected, the multiplicity of infection and the presence of Retronectin (Takara Bio, Madison, WI, USA) influenced efficiency of the transduction process. In preliminary pre-transplant studies, the presence of Retronectin appeared to increase transduction efficiency and mean fluorescence intensity, as did increasing multiplicity of infection (Figure 2 ). On the basis of these preliminary (non-statistically validated) observations, which were in agreement with the numerous recombinant fibronectin studies found in the literature, [16] [17] [18] we elected to include Retronectin in our protocol.
We next assessed the repopulating capacity of increasing numbers of our HSC populations ( Figure 3a) .
In addition to the quantitative assessment provided by repopulation analysis, it is important that the quality of HSC function also be assessed. Analysis of lineage output and hematopoietic organ engraftment confirm that the transduced cells from both KSL-and SLAMenriched populations provided balanced multilineage reconstitution of all hematopoietic compartments. There were no statistically significant differences in the PB MNC GFP + Figure 1 Schematic representation of the backbone of the human immunodeficiency virus (HIV)-derived lentivirus vector used in this study. The transgene is composed of the modified myeloid proliferative sarcoma virus promoter (MND promoter), 30 driving the enhanced green fluorescent protein (eGFP) reporter gene. 24 The MND promoter, as described by Robbins et al., was cloned from murine retrovirus long terminal repeat (LTR) templates and modified by selected oligonucleotides by PCR amplification. The sequence of the MND promoter used in this publication is available on request. 23 The envelope used was that of vesicular stomatitis virus G (VSVg). Briefly, 293 T cells were cotransfected with plasmids as previously described. Viral particles were harvested, concentrated by ultracentrifugation, aliquoted, snap frozen and stored at À80 1C. Functional viral titers were determined on 293 T cells also as described (unconcentrated titers were between 10 6 and 10
7
; functional concentrated titers ranged from 10 9 to 10 10 ). 31 The rev response element (RRE) and the Woodchuck hepatitis virus posttranscriptional regulatory element (WPRE) enhance transcription and expression of the transgenes as indicated above in the schematic vector structures. (Figure 4 ). The few statistically significant differences in lineage reconstitution between SLAM and KSL cells, and between transduced and non-transduced cells of each type are difficult to explain without further experimentation. The former may relate to heterogeneity among stem cell populations with respect to fate determination and the later may reflect subtle functional effects of the vector or transgene on lineage determination. Heterogeneity in the functional output between these populations would not be surprising. Weksberg et al. 19 recently showed heterogeneity within the SP population for SLAM and KSL expression. Using combinations of these markers resulted in the identification of two long-term repopulating populations, CD150 
SP
KSL cells showed a tendency to skew toward lymphoid production at the expense of myeloid production. As this population would have been reduced in our SLAM isolation, but likely preserved in our KSL isolation, it is possible that the observed skewing toward myeloid production is related to this previously identified functional heterogeneity in the total HSC compartment.
The most sensitive assessment of HSC function is the in vivo capacity of the HSCs to engraft and compete against other populations. There were two internal controls within the design of this experiment. The first consisted of cells that were treated identically to transduced cells, but were not transduced (30-40% of donor cells). These cells represent a control for detrimental effects of the vector or transgene. The second consisted of competing freshly isolated BM MNCs that serve as a control for detrimental effects of the enrichment and transduction protocols. The first observation related to competitive capacity of transduced cells is that levels of GFP + cell chimerism remained stable throughout the period of analysis for all donor cell doses (Figure 3a) , suggesting that once engraftment occurred, there was equal competitive capacity of the transduced cells with both the non-transduced CD45.2 (donor) HSCs and the syngeneic BM MNCs. In those mice that had been transplanted with the highest cell dose (5 Â 10 4 enriched HSCs), we assessed the competitive capacity of transduced donor cells relative to non-transduced donor cells and syngeneic competitor cells. At 4 months after transplantation, an interval that reflects long-term repopulating cell activity, an average of 77 and 86% PB MNCs were of donor origin (CD45. 5 cells per well in a final volume of 500 ml of StemPro medium (Invitrogen, Carlsbad, CA, USA) supplemented with 100 ng ml À1 of recombinant stem cell factor (SCF), 100 ng ml À1 of thrombopoietin (TPO) (PeproTech Inc, Rocky Hill, NJ, USA) and 5 g ml À1 of protamine sulfate in a 48-well plate pre-coated or not with Retronectin as indicated. Cells were exposed to virus at the indicated MOIs for 14-16 h at 37 1C in a 5% CO2-humidified incubator. Cells were washed twice, re-plated in new uncoated wells in the presence of the hematopoietic growth factorsupplemented media without protamine sulfate for fluorescence-activated cell sorting (FACS) analysis after a final culture of 72 h. For the repopulation experiments, enriched HSCs were incubated in protamine sulfate-containing growth factor-supplemented media in coated plates and exposed to virus at an MOI of 100 for 14-16 h. Cells were then harvested, washed twice in cold phosphate-buffered saline and concentrated for intravenous administration. An aliquot of any preparation was reserved for culturing to assess transduction efficiency as indicated above. An aliquot of any enriched HSC population was cultured in the absence of virus and used as a negative control in the FACS analysis. Efficiency of gene transfer was assessed determining the proportion of green fluorescent protein (GFP)-expressing cells by flow cytometry.
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2 Â 10 5 radioprotective, syngeneic, freshly isolated, BM MNCs that were cotransplanted with the donor cells ( Figure 5 ). Thus it would appear that once engrafted, the transduced cells were able to maintain their competitive capacity compared with both control cell populations. It is remarkable that at all time points, the ratio of transduced to non-transduced CD45.2 (donor) cells remained B60/40 for both KSL and SLAM-enriched cells. This suggests that the ex vivo assay for efficiency of gene transfer was predictive of the frequency of HSC transduction, and that the viral and transgene products had no detrimental effects on HSC engraftment or ) recipient mice were lethally irradiated before transplantation (450 cGy twice, 3 h apart, at a dose rate of 2.2 cGy min À1 in a 137Cs gamma irradiator). The three doses of transduced B6 (CD45.2, H-2Kb) HSCs were combined with 2 Â 10 5 syngeneic (CD45.1, H-2Kb, GFP À ) freshly isolated bone marrow mononuclear cells (BM MNCs), and were suspended in phosphate-buffered saline (PBS) and injected through tail vein using a 27-G needle in a total volume of 200 ml. Blood chimerism was assessed by measuring percentages of GFP + peripheral blood mononuclear cells (PB MNCs) at 1, 2, 3 and 4 months posttransplantation. At each time point, the mice were bled through the retro-orbital sinus and the blood was collected into tubes containing heparinized PBS (100 ml of blood into 10 ml PBS). PB MNCs were separated by density gradient, washed twice in cold PBS and stained with propidium iodide (PI) before flow cytometry. Multilineage blood chimerism was evaluated by dual-color cytometry (GFP/lin À PE). All PE (phycoerythrin)-conjugated antibodies used for lineage analysis (CD45, CD45.1, CD3, B220, Mac-1 and Gr-1) were purchased from BD Biosciences (San Jose, CA, USA), and analytical flow cytometry was performed on a FACSCalibur (BD Biosciences). Nonspecific FcR binding was blocked by anti-FcR antibodies, and PI (Sigma-Aldrich Corp, St. Louis, MO, USA) was used to exclude dead cells. Statistical analysis was performed using the Student t-test (always paired samples), and a double-tail P-value p0.01 was considered significant. Mice were killed, and bone marrows, spleens and thymuses were harvested. Single-cell suspensions were created by gently mincing the organs and passing the cell suspensions through 70-mm filters. After this step, single-cell suspensions were processed by density gradient to obtain mononuclear cells, which were subsequently stained with propidium iodide (PI) before flow cytometry.
SLAM-enriched hematopoietic stem cells P Laje et al subsequent function. In addition, the ratio of donor to syngeneic cells remained constant for the period of the study, supporting no permanent detrimental effects of the enrichment or transduction protocols on HSC function relative to freshly isolated cells. However, it is important to note that based on estimated HSC content, the SLAM and KSL populations were not equal to fresh syngeneic BM in their ultimate contribution to hematopoiesis. This could be owing to loss of HSC content with the enrichment and culture manipulations or to a homing and engraftment defect in the manipulated cell populations, as has been previously reported. 20, 21 To further assess the long-term repopulating capacity of the transduced SLAM-HSCs, we performed a secondary transplantation experiment. Primary donor CD45.2 CD150 + /CD48 À cells were transduced using the described abbreviated protocol. Primary recipients (lethally irradiated, CD45.1 females) received 1.5 Â 10 4 transduced cells (transduction efficiency E60%) along with 2 Â 10 5 freshly isolated syngeneic BM MNCs. At 4 weeks after the primary transplantation, the mean GFP chimerism in PB MNCs ranged from 3.3 to 22% (mean: 9.5%). The BM MNC of the primary recipients (n ¼ 15) were collected and pooled (GFP + ¼ 22%). Each secondary recipient (lethally irradiated, CD45.2 females) received 6 Â 10 7 of these BM MNC. At 4 weeks after the transplantation, all secondary recipients (n ¼ 10) showed GFP expression. The mean GFP chimerism was 19.6% in the BM MNC compartment (range: 9.2-38.9), 11.8% (range: 9.9-20.7) in the spleen, 4.1% (range: 0.1-12.7) in the thymus and 15.3% (range: 9.7-22.2) in the PB MNC compartment ( Figure 6 ). The fact that all secondary recipients were chimeric in all compartments confirms the original transduction of HSCs. The mean GFP chimerism in the BM MNC compartment of the secondary recipients was remarkably similar to the chimerism of the donor cells (19.6 and 22%, respectively), supporting the stability of GFP expression over time and cellular expansion. The results of the secondary transplantation experiment for the SLAM-HSCs are similar to those obtained after transduction, transplantation and secondary transplantation of KSL-HSC. [22] [23] [24] It is important to note that the populations used in this study were not purified HSCs, which require a much more stringent isolation strategy, but rather populations highly enriched for HSCs that would provide practical advantages for HSC-directed gene transfer studies. Nevertheless, the relative HSC content of each population is important for interpretation of our results. To estimate the relative HSC content, we calculated repopulating units (RUs) 25, 26 relative to the standard repopulating ability of 1 Â 10 5 competitor cells, according With recognition of the ability of lentiviral vectors to transduce non-dividing cells, it has become apparent that, although minimal stimulation of HSC is necessary to avoid apoptosis, a brief exposure to two hematopoietic growth factors provides adequate support for transduction without loss of repopulating capacity. 22, 27 Other factors, such as the addition of recombinant fibronectin or polybrene, have been shown to improve the transduction efficiency without affecting the behavior of the transduced cells. 28, 29 This study recognizes the contribution of multiple other investigators and incorporated those features and modifications to design a brief and abbreviated transduction protocol that was highly efficient in transducing HSCs. The protocol avoided cell pre-stimulation, included no interleukin exposure and used only stem cell factor and thrombopoietin as HSC growth factors. The transduction efficiency of up to 70% after 14-16 h of viral exposure for both enriched cell populations compares favorably with other protocols, many of which require longer and more involved cell manipulations. More importantly, the data from the competitive repopulation studies suggest that the engraftment potential of the manipulated cells and their subsequent repopulating capacity did not seem to be adversely affected, given that as few as 500 transduced cells were able to partially reconstitute the irradiated recipients. On the basis of the recent publications, it is likely that even further abbreviation of the transduction protocol can be accomplished without loss of transduction efficiency, although it is unclear whether this will correlate with further beneficial effects on repopulating capacity or HSC function. Unfortunately, our abbreviated protocol of transduction precludes sorting of transduced cells before transplantation because of the time required for GFP expression after lentiviral transduction (48-72 h). Therefore, in all our transduction experiments, an aliquot of cells was washed, re-suspended in vector-free HSCsupportive media and analyzed by flow cytometry, 72 h after vector exposure. We felt that culture during this period of time before transplantation would likely result in significant loss of long-term repopulating capacity.
Our objective in this study was to determine whether the simpler SLAM protocol resulted in a transduced HSC product that was equal to or better than the standard KSL isolation using an optimized lentiviral transduction protocol. The results show that SLAM cells are at least as good, if not better than KSL cells, from the practical perspective of transduction efficiency and posttransduction repopulating capacity. Furthermore, the results confirm that the SLAM enrichment protocol represents a pragmatic, relatively simple and effective HSC isolation approach for murine hematopoietic gene transfer studies.
